![Charles Link](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Link
Fundador en
Syncromune, Inc.
.
Perfil
Charles J.
Link was the founder of NewLink Genetics Corp.
(1999), serving as Chairman, Chief Executive & Scientific Officer from 2003 to 2019; Central Iowa Hospital Corp.
(1995), serving as Director from 1995 to 2003; and Syncromune, Inc. (2020), serving as Executive Chairman.
Current jobs include Director at NovaScan, Inc. (2020 - present), Director at ImmunSYS, Inc. (present), and Director at Viewpoint Molecular Targeting, Inc. (2021 - present).
Former jobs include Chairman & Chief Executive Officer at BioProtection Systems Corp.
(2005 - 2009), Independent Director at QSAM Biosciences, Inc. (2021 - 2024), and Chief Executive & Scientific Officer at Lumos Pharma, Inc. Education includes a doctorate from Stanford University School of Medicine.
Cargos activos de Charles Link
| Empresas | Cargo | Inicio |
|---|---|---|
ImmunSYS, Inc.
 ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cancer immunotherapy products | Director/Miembro de la Junta | - |
NovaScan, Inc.
 NovaScan, Inc. Medical SpecialtiesHealth Technology Manufactures cancer detection instrument | Director/Miembro de la Junta | 01/01/2020 |
Viewpoint Molecular Targeting, Inc.
 Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Director/Miembro de la Junta | 18/05/2021 |
Syncromune, Inc.
 Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops intratumoral immunotherapy platform for treating metastatic solid tumors | Fundador | 01/01/2020 |
Antiguos cargos conocidos de Charles Link.
| Empresas | Cargo | Fin |
|---|---|---|
QSAM Biosciences, Inc.
 QSAM Biosciences, Inc. Chemicals: AgriculturalProcess Industries Manufactures compost | Director/Miembro de la Junta | 02/05/2024 |
| LUMOS PHARMA, INC. | Director Ejecutivo | 03/08/2019 |
| LUMOS PHARMA, INC. | Director Ejecutivo | 03/08/2019 |
BioProtection Systems Corp.
 BioProtection Systems Corp. BiotechnologyHealth Technology Manufacturers biological products | Presidente | 01/01/2009 |
Central Iowa Hospital Corp. | Fundador | 01/01/2003 |
Formación de Charles Link.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
22
Relaciones de 1er grado
10
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 10 |
|---|---|
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops, and commercializes novel immunotherapeutic products for treatment of cancer | Health Technology |
BioProtection Systems Corp.
BioProtection Systems Corp. BiotechnologyHealth Technology Manufacturers biological products | Health Technology |
Central Iowa Hospital Corp. | |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
QSAM Biosciences, Inc.
QSAM Biosciences, Inc. Chemicals: AgriculturalProcess Industries Manufactures compost | Process Industries |
NovaScan, Inc.
NovaScan, Inc. Medical SpecialtiesHealth Technology Manufactures cancer detection instrument | Health Technology |
ImmunSYS, Inc.
ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cancer immunotherapy products | Health Technology |
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Lumos Pharma, Inc.
 Lumos Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and markets therapeutics for rare diseases | Health Technology |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops intratumoral immunotherapy platform for treating metastatic solid tumors | Health Technology |
- Bolsa de valores
- Insiders
- Charles Link
